Here, in the zebrafish colitis model, DSF treatment significantly inhibited the abnormal increase in the expression of pro-inflammatory cytokines (tnfa, il1b, and il6) and the decrease in the expression of the anti-inflammatory factor il10. This evidence concerns the gene IL1B and colitis.